PICTON MAHONEY ASSET MANAGEMENT - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 275 filers reported holding HAEMONETICS CORP in Q3 2019. The put-call ratio across all filers is 2.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
PICTON MAHONEY ASSET MANAGEMENT ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2020$5,715,000
-38.7%
63,820
-31.8%
0.33%
-37.6%
Q1 2020$9,322,000
-31.1%
93,540
-20.6%
0.53%
-42.2%
Q4 2019$13,527,000
-14.8%
117,740
-6.4%
0.91%
-18.4%
Q3 2019$15,875,000
-1.3%
125,840
-5.9%
1.12%
+1.1%
Q2 2019$16,089,000
+37.0%
133,700
-0.4%
1.10%
+24.3%
Q1 2019$11,744,000
-28.3%
134,260
-18.0%
0.89%
-39.3%
Q4 2018$16,371,000
-14.3%
163,651
-1.8%
1.46%
+9.0%
Q3 2018$19,093,000
+26.1%
166,648
-1.3%
1.34%
+23.6%
Q2 2018$15,138,000
+34.6%
168,800
+9.8%
1.09%
+34.2%
Q1 2018$11,250,000
+490.6%
153,800
+368.9%
0.81%
+495.6%
Q4 2017$1,905,00032,8000.14%
Other shareholders
HAEMONETICS CORP shareholders Q3 2019
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders